Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-14-001818
Filing Date
2014-06-10
Accepted
2014-06-10 17:41:39
Documents
1
Period of Report
2014-06-06

Document Format Files

Seq Description Document Type Size
1 form4-06102014_020630.html 4  
1 form4-06102014_020630.xml 4 3899
  Complete submission text file 0001415889-14-001818.txt   5279
Mailing Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 14903042